Engflag

Vetprofen

Quick links to important sections

Vetprofen

Vetprofen_EN

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vetprofen

Property Description
Active ingredient Carprofen (INN)
Form Oral Tablets or Caplets (often flavored)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Relief of pain and inflammation
Origin Synthetic

What is Vetprofen and its Core Identity?

Vetprofen is the trade name for the drug entity Carprofen, a synthetic, single-ingredient medicinal product intended exclusively for veterinary medicine, primarily for use in dogs. It is classified as a Prescription Animal Drug, meaning its administration must be authorized and managed by a licensed veterinarian. This regulated status affirms the drug's established therapeutic efficacy.

The active compound, Carprofen, belongs to the Propionic acid group and is supplied for oral administration, typically as flavored tablets or caplets. The use of a palatable oral form is a differentiating feature designed to enhance compliance and simplify the patient care process, particularly in managing chronic conditions.

Carprofen: What Pharmacological Class Does it Belong To?

The active ingredient, Carprofen, is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), belonging to the carbazole class of derivatives. This core classification indicates the drug's primary function is to manage the body’s inflammatory cascade. The efficacy of Carprofen in managing discomfort is recognized for its consistent performance in veterinary applications.

Carprofen is characterized as a COX-2 preferential inhibitor. This preference means it primarily targets the enzyme subtype associated with inflammation and pain signaling, which is essential to its mechanism. This mechanism allows the drug to address the general symptoms of pain and swelling.

What is the General Purpose of This NSAID?

The general purpose of Vetprofen is to provide systemic relief from discomfort and immobility by addressing both inflammation and associated pain. The drug's action intervenes early in the inflammatory pathway, reducing the synthesis of chemicals that cause stiffness and soreness.

By providing strong analgesic and anti-inflammatory activity, the drug helps support the patient’s overall physical comfort and function. For instance, in a common scenario like chronic osteoarthritis, the drug's use is aimed at reducing joint inflammation and improving the patient's willingness to move. This fundamental benefit makes it a core pharmaceutical option for sustained modulation of the body’s response to injury or chronic irritation.

Regulatory References

  1. FDA Official Labeling

What side effects are possible with Vetprofen?

Possible Side Effects and Safety Information

Vetprofen (carprofen) is a nonsteroidal anti-inflammatory drug (NSAID) whose safety profile is primarily defined by the class effects of cyclooxygenase inhibitors, which may impact the gastrointestinal, renal, and hepatic systems.

Documented Adverse Reactions

Adverse reactions reported in field studies most commonly involve the gastrointestinal system, including vomiting (4%) and diarrhea (4%), as well as changes in appetite (inappetence) and lethargy. More serious, though rare, adverse events have been reported through post-approval surveillance, which may include gastrointestinal ulceration, gastrointestinal bleeding, acute hepatic toxicity, acute renal failure, and, in rare instances, death.

System-Organ Class Key Adverse Effects
Gastrointestinal Vomiting, diarrhea, inappetence, ulceration, bleeding
Hepatic Acute hepatic toxicity
Renal (Urinary) Acute renal failure, tubular necrosis
Neurologic Seizures, paralysis, behavioral changes
Hematologic Immune-mediated disorders

Safety Considerations and Restrictions

Vetprofen is contraindicated for use in patients with a known hypersensitivity to the drug or severe allergic reactions to aspirin or other NSAIDs. Caution is advised when administering the medication to animals that are dehydrated, on concurrent diuretic therapy, or those with existing renal, cardiovascular, or hepatic dysfunction, as these conditions increase the risk of serious adverse events.

Concomitant Use: The use of Vetprofen concurrently with other NSAIDs or corticosteroids is generally restricted due to the heightened risk of serious adverse reactions, particularly gastrointestinal ulceration and perforation.

Populations Not Studied: The safety of this medication has not been established for use in dogs under 6 weeks of age, pregnant dogs, or dogs used for breeding purposes. It is strictly indicated for use in dogs only and is contraindicated in cats.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile of Vetprofen (Carprofen) based on toxicity to specific physiological systems. Documented manifestations include severe gastrointestinal signs such as vomiting, diarrhea, anorexia, melena (black/tarry stools), and the potential for gastrointestinal ulceration and bleeding. Systemic toxicity extends to acute hepatic toxicity (jaundice, elevated liver enzymes) and acute renal failure (azotemia, polyuria).

Severe outcomes documented in the regulatory record include the potential for seizures, paralysis, and in rare instances, death resulting from unmanaged organ failure. The regulatory guidance mandates that if a subject has consumed the drug above the labeled dose or exhibits severe signs of intolerance, the drug must be discontinued immediately, and the owner must contact a veterinarian for urgent assistance.

There is no known specific antidote for Carprofen overdose. Management is restricted to symptomatic and supportive treatment, which requires mandatory monitoring of gastrointestinal, renal, and hepatic function. Specific warnings note that patients with pre-existing organ dysfunction or those that are dehydrated are at greatest risk for renal toxicity.

Therapeutic Uses of Vetprofen

What Vetprofen Treats: Main Uses and Benefits

Vetprofen (Carprofen) is relevant for easing symptoms related to inflammatory or irritative states that often lead to noticeable physical discomfort in dogs. The medication is commonly used across two core therapeutic domains: managing discomfort associated with osteoarthritis and managing pain associated with both soft tissue and orthopedic surgeries.

In clinical scenarios, the medicine is applied in conditions where symptoms may intensify temporarily, such as during flare-ups of chronic joint issues or in the period after a medical procedure. It is relevant for easing symptom clusters that create functional strain, including lameness, stiffness, and localized swelling. This supportive relief may assist patients with managing difficult episodes.

“This medication is commonly used to help with the sustained management of chronic joint pain and to provide acute support during the post-operative recovery phase.”

By assisting with the overall symptom load, Vetprofen supports the patient during episodes of heightened discomfort and contributes to improved day-to-day comfort.

Key Focus: Symptomatic Relief for Stiffness and Acute Pain

Regulatory References

  1. U.S. FDA’s Animal Drugs @ FDA database

Eligibility and Restrictions for Use

Who Can and Cannot Use Vetprofen?

The eligibility for Vetprofen (Carprofen) is strictly defined by regulatory labeling for veterinary use. It is approved for use only in dogs.

Absolute Contraindications (Do Not Use)

Regulatory documents classify the following populations and conditions as absolute contraindications:

  • Cats: Use is strictly prohibited.
  • Hypersensitivity: Dogs with a known allergy to Carprofen or any other Non-Steroidal Anti-Inflammatory Drug (NSAID).
  • Severe Organ Dysfunction: Dogs with severe cardiac, hepatic (liver), or renal (kidney) disease.
  • Gastrointestinal Risk: Dogs with a possibility of gastrointestinal ulceration or bleeding, or a blood dyscrasia.

Restricted Use and Caution

Use is either not established or requires specific caution in other populations:

  • Age Limits: The safe use has not been established in animals less than 6 weeks of age. Aged or senior dogs may involve additional risk.
  • Pregnancy/Breeding: Use is not established in pregnant, lactating, or breeding dogs.
  • Conditional Caution: Use should be avoided in dogs that are dehydrated, hypovolaemic (low blood volume), or hypotensive (low blood pressure), due to potential renal risk. Dogs with pre-existing organ dysfunction also require caution.

What should I know about interactions with other medicines?

The regulatory interaction profile for Vetprofen (Carprofen) establishes mandatory restrictions concerning co-administration with several other drug classes. These prohibitions and restrictions are categorized based on the mechanism of the interaction, primarily focusing on additive toxicity (pharmacodynamic reinforcement) and changes in drug concentration (pharmacokinetic competition).

Contraindicated and High-Risk Combinations

Co-administration with Glucocorticoids (Corticosteroids) and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is strictly prohibited by regulatory authorities. This restriction is due to the documented risk of severe gastrointestinal ulceration and perforation resulting from pharmacodynamic reinforcement between these drug classes.

Restrictions Based on Drug Action

Concurrent administration with Anticoagulants should be avoided due to the potential for increased bleeding risk. Similarly, co-administration with Potentially Nephrotoxic Drugs is restricted, as it presents an additive risk of renal toxicity.

Pharmacokinetic Interaction and Timing

Carprofen is highly bound to plasma proteins. This high binding capacity creates a pharmacokinetic competition with other highly protein-bound medicines, an effect officially documented as potentially increasing the exposure and toxic effects of the co-administered drug. When switching from Carprofen to another NSAID or corticosteroid, official documents mandate a treatment-free period (washout) to mitigate the compounding of adverse effects.

Population-Specific Constraint

Use of Carprofen is officially restricted in patients who are dehydrated, hypovolaemic, or hypotensive. These conditions increase the potential for additive renal toxicity when the drug is combined with other potentially compromising agents, a constraint tied directly to the overall interaction profile.

Mechanism of Action

Core Action: Preferential COX-2 Enzyme Inhibition

The primary mechanism of Carprofen is its targeted, reversible inhibition of the Cyclooxygenase-2 (COX-2) enzyme, which is responsible for converting arachidonic acid into Prostaglandin E2 ( PGE2) . By preferentially blocking this molecular step, the drug reduces the synthesis of this inflammatory mediator, altering the initial molecular steps within the physiological response.

Modulating Nociceptive and Vascular Pathways

The consequence of reduced PGE2 affects multiple signaling pathways. PGE2 normally sensitizes both peripheral pain receptors (nociceptors) and central nervous system centers, and its suppression modulates the sensitivity of these peripheral nociceptors. This PGE2 reduction also limits excessive local vasodilation and capillary permeability, resulting in mitigation of local edema.

Non-Prostanoid Modulation and Mechanistic Constraints

Beyond the COX pathway, the mechanism includes an inhibitory influence on Matrix Metalloproteinases (MMPs), enzymes that mediate the degradation of cartilage matrix. This non-prostanoid modulation influences the drug’s mechanistic activity spectrum. However, the core COX mechanism is functionally limited to situations where the pathway activation is mediated by PGE2, and its preferential binding affinity is not uniform across all tissue environments.

Dosage and Administration Information

How to Use Vetprofen: Official Administration Guidelines

Vetprofen (Carprofen) use is structured according to official guidelines that define its administration route, dosing, and schedule, and is restricted to use by or on the order of a licensed veterinarian.

Administration Scope

The approved forms of the medicine allow for two primary methods of delivery, each with distinct requirements.

Category Official Guideline
Route of Administration Oral (tablets/caplets) or Subcutaneous (injectable solution, administered by a veterinarian).
Dosing Schedule The standard total initial daily dose is 4.4 mg/kg (2.0 mg/lb) of body weight. The dose may be maintained or reduced based on patient response for long-term use.
Timing in relation to meals Oral caplets may be administered with or without food.
Preparation Requirements Oral caplets are scored to facilitate accurate splitting and ensure precise dosage. The injectable solution is provided at 50 mg/mL.
Age-Group Rules This drug is intended for use in dogs only; safe use has not been established in dogs less than six weeks of age.
Missed-Dose Rules If a dose is missed, it may be administered when remembered. However, if it is near the time for the next dose, the missed dose should be skipped to avoid doubling the dose.

Frequency and Procedural Structure

The total daily dose can be delivered using one of two approved frequency patterns.

Frequency Pattern:

  • Once Daily (q24h): The entire 4.4 mg/kg total daily dose can be given in a single administration.
  • Twice Daily (q12h): Alternatively, the total daily dose may be divided and administered as 2.2 mg/kg twice daily.

Connection to the overall use protocol:

The instructions mandate a thorough physical examination and laboratory testing be considered prior to and periodically during administration of the NSAID. This official structure ensures standardized administration using the approved dose ranges, whether for short-term control or long-term management.

Recent Clinical Evidence

Vetprofen: Recent Clinical Evidence

Combination Therapy for Chronic Pain

Research has explored the potential of combining [Drug A] and [Drug B] in contexts exploring treatment for moderate to severe pain, such as in rheumatoid arthritis and certain types of neuralgia.

Research has characterized this combination as one area of investigation in pain management.

Key Findings on Efficacy

Comparative Reduction in Pain Scores

One large-scale meta-analysis included a comparison of patients taking the combination versus monotherapy with [Drug A] alone, and reported findings related to average pain scores. The studies used standardized pain scales (e.g., VAS or NRS) to measure the change from baseline.

Studies evaluated this approach in participants with chronic pain lasting more than three months, with outcomes detailed in the studies.

Opioid-Sparing Potential

Research has explored whether this approach may be associated with a reduction in the use of opioid medication in chronic pain management. Further studies are ongoing to characterize this potential area of investigation and its clinical implications.

Dosage and Tolerability

Studies evaluated starting dosages, which included 10mg/day of [Drug A] and 50mg/day of [Drug B] in the research protocols. Protocols examined starting dosages and detailed adjustments based on prespecified criteria.

Safety trials examined the combination in adult participants. The reports included data on the incidence and severity of observed side effects. The report provided details on the types and frequency of adverse events observed. Data on the rate of severe adverse events was included in the trial reports.

Patient Adherence

Trials also investigated patient adherence to the combination regimen. Reports suggested that adherence rates were comparable to other chronic pain medications studied, although data remains limited on long-term compliance beyond one year.

Key Studies & References Review Combination pharmacotherapy for management of chronic pain: from bench to bedside

Frequently Asked Questions (FAQ)

Common questions about Vetprofen (FAQ)

Q: How does Vetprofen's mechanism of action differ from general pain relievers?

Official documents describe Vetprofen (Carprofen) as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its primary action involves the preferential inhibition of the Cyclooxygenase-2 (COX-2) enzyme, which is a key part of the body's inflammatory process. This specific anti-inflammatory action differentiates it from some general pain relievers that may work through different chemical pathways.

Q: Can Vetprofen be used for pain relief in addition to its main described purpose?

Yes, regulatory documents indicate that Vetprofen is officially intended for the control and relief of both pain and inflammation. This confirms its use for addressing discomfort and swelling associated with conditions like osteoarthritis, as well as for general pain control.

Q: What is the typical timeframe before a person might notice the described effects of Vetprofen?

Pharmacokinetic studies, which describe how the drug is handled by the body, indicate that the active ingredient, Carprofen, typically reaches its highest concentration in the bloodstream within 1 to 3 hours after an oral dose. This timeframe corresponds to when the active ingredient is at its highest concentration in the bloodstream.

Q: What is the general duration of time a patient is expected to be on Vetprofen?

Official indications show the drug is suitable for conditions that may require both short-term and sustained management. For example, it is indicated for post-operative pain (short-term) and for pain associated with chronic conditions like osteoarthritis (long-term). The duration of use is determined by the patient's underlying condition.

Q: Does research evidence for Vetprofen mainly focus on short-term use or long-term use?

Regulatory safety studies have examined the drug across various durations to understand its effects. The research has included protocols for both short-term use (such as studies lasting 28 days) and long-term use (such as studies lasting up to one year) in healthy subjects.

Q: Why does Vetprofen require a prescription?

Official labeling contains a caution statement noting that Federal law restricts the drug’s distribution. This classification means Vetprofen is a Prescription Animal Drug, and its administration is restricted to being carried out by or on the order of a licensed veterinarian.

Q: Is Vetprofen considered a controlled substance?

According to official product information, Vetprofen is described as a non-narcotic medication and is not listed in any official DEA schedules. This confirms that it is not classified as a controlled substance.

Q: What type of monitoring is sometimes associated with long-term Vetprofen use?

Because Vetprofen is an NSAID, there is a recognized potential for effects on the gastrointestinal, renal (kidney), and hepatic (liver) systems. This potential risk is why regulatory guidance mentions the need to consider appropriate laboratory monitoring for patients receiving long-term treatment.

Q: Can Vetprofen affect the results of certain lab tests?

Official adverse reaction reports include the documentation of elevated hepatic enzymes and abnormal liver function tests. This indicates that the medication has the potential to influence the results of specific laboratory evaluations.

Q: What is the process for Vetprofen being cleared from the body?

The drug is primarily processed and broken down (biotransformed) in the liver. The resulting inactive products are then eliminated from the body, with the majority of this elimination occurring through the feces and a smaller portion through the urine.

Q: How is the safety of Vetprofen monitored after it has been approved?

The safety of the drug is continuously monitored after it is made available to the public. Regulatory documents include data gathered from post-approval surveillance (also known as post-marketing surveillance), which is the system used to collect and evaluate reports of adverse events over time.

Q: Do official materials suggest Vetprofen is habit-forming?

Official regulatory materials confirm that Vetprofen is described as a non-narcotic medication. It is not listed as a controlled substance and is not associated with properties of dependence.

Q: Is Vetprofen available as a generic medication?

Official product information shows that the active ingredient, Carprofen, is approved and marketed by multiple companies. This is supported by the approval of several Abbreviated New Animal Drug Applications (ANADAs), confirming that generic versions are available.

Q: What should a patient know about Vetprofen and sun exposure?

While specific warnings about sun exposure are not typically detailed in the official label, official reports do list various dermatologic (skin) reactions as possible side effects. These documented effects include conditions such as redness and itching.

Q: Are there any dietary restrictions mentioned for patients taking Vetprofen?

Official administration instructions state that the oral caplets may be administered with or without food. Beyond this, no broad, restrictive dietary instructions are mentioned in the official labeling.

Q: What types of conditions is Vetprofen not suitable for?

The medication is not suitable for patients with a known hypersensitivity to the drug or those with severe pre-existing diseases of the kidney, liver, or heart. Its use is also avoided in patients with a potential for gastrointestinal bleeding or ulceration.

Q: Does Vetprofen have different dosage forms (e.g., tablet, liquid)?

Official product information confirms that the drug is supplied in multiple forms for administration. These include oral forms, such as caplets or chewable tablets, and a sterile injectable solution for administration by a professional.

Q: If a side effect occurs, how quickly might it resolve after stopping the medication?

Reports suggest that mild, common side effects may resolve once the medication is stopped. However, official guidance advises that if any adverse reaction is observed, the treatment should be discontinued immediately and medical guidance is recommended.

Q: Is there a concern about Vetprofen's use in individuals with heart conditions?

Yes, regulatory documents advise caution when the drug is given to patients with existing cardiovascular dysfunction. This warning is related to the possibility of increased risk for serious adverse events in these populations.

Q: What is the role of Vetprofen in managing chronic conditions?

Official indications show the drug is used to relieve the pain and inflammation associated with osteoarthritis. This confirms the drug's role in the long-term, sustained management of chronic inflammatory and painful conditions.

Q: What does official guidance say about driving or operating machinery while taking Vetprofen?

Adverse reaction reports include the potential for side effects such as lethargy, incoordination, and seizures. These neurologic and behavioral changes are signs that could affect a patient's normal level of alertness and coordination.

Q: Does official information address the use of Vetprofen during pregnancy or breastfeeding?

Official precautions explicitly state that the safe use of this medication has not been established for dogs that are pregnant, lactating (breastfeeding), or being used for breeding purposes.

Q: Are there different strengths of Vetprofen tablets available?

Yes, official product information indicates that the oral tablets are supplied in multiple concentrations. Common strengths include tablets of 25 mg, 75 mg, and 100 mg caplets or chewable tablets, allowing for flexibility in administration.

Q: Is there a link between Vetprofen and liver function issues?

Official documents report the potential for rare but serious adverse events, including acute hepatic toxicity (liver poisoning) and elevated liver enzymes. For this reason, the drug is contraindicated in patients with severe liver disease.

Q: Do any official documents describe the effect of Vetprofen on fertility?

The regulatory documents state that the safe use of the medication has not been established for animals that are used for breeding purposes.

Q: Are there any known drug-disease interactions mentioned in the official prescribing information?

Yes, the prescribing information notes that use is contraindicated or requires caution in patients with certain conditions. Examples include severe cardiac, renal, or hepatic dysfunction, as well as pre-existing gastrointestinal ulceration or bleeding disorders.

Q: How should a patient manage a mild side effect while on Vetprofen?

Official guidance advises that if signs of intolerance or adverse reactions are observed, the therapy should be discontinued. Medical guidance is recommended to determine the next steps.

Q: Are skin reactions a documented side effect of Vetprofen?

Yes, official adverse event reports list various dermatologic reactions as possible side effects. Documented effects include pruritus (itching) and erythema (redness).

Q: What does the research say about the long-term safety of Vetprofen?

Official safety studies have examined the drug for periods of up to one year in healthy subjects. Regulatory materials note that the potential for class-related adverse effects (affecting GI, kidney, or liver function) may be higher during long-term use.

How should Vetprofen be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Vetprofen (carprofen) is governed by specific regulatory requirements to maintain its stability and effectiveness. The tablets must typically be stored below 25 C to 30 C, in a dry place, and protected from light. For the injectable solution, unopened vials require refrigeration (2 C to 8 C) and must not be frozen.

Stability and Handling

Stability rules require keeping the medicine in its original container and protected from moisture. Once an injectable vial is opened, it typically has a shelf-life of 28 days under refrigeration. Divided tablet portions must be used within a very short timeframe, often 3 days.

Disposal and Safety

Vetprofen must be kept out of the sight and reach of children and animals. The official disposal protocol mandates that unused or expired product must not be discarded with household waste or wastewater; instead, it must be disposed of through authorized medicine take-back schemes to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vetprofen found in:

A-Z Index: